246 related articles for article (PubMed ID: 24735767)
1. Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma.
Voong KR; McSpadden K; Pinnix CC; Shihadeh F; Reed V; Salehpour MR; Arzu I; Wang H; Hodgson D; Garcia J; Aristophanous M; Dabaja BS
Radiat Oncol; 2014 Apr; 9():94. PubMed ID: 24735767
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
3. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerations.
Fiandra C; Filippi AR; Catuzzo P; Botticella A; Ciammella P; Franco P; Borca VC; Ragona R; Tofani S; Ricardi U
Radiat Oncol; 2012 Nov; 7():186. PubMed ID: 23122028
[TBL] [Abstract][Full Text] [Related]
4. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma.
Paumier A; Ghalibafian M; Gilmore J; Beaudre A; Blanchard P; el Nemr M; Azoury F; al Hamokles H; Lefkopoulos D; Girinsky T
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1522-7. PubMed ID: 21705151
[TBL] [Abstract][Full Text] [Related]
6. A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy.
Fan LL; Luo YK; Xu JH; He L; Wang J; Du XB
J Appl Clin Med Phys; 2014 Sep; 15(5):4624. PubMed ID: 25207559
[TBL] [Abstract][Full Text] [Related]
7. Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma.
Chen X; Jin D; Wang S; Li M; Huang P; Dai J
J Appl Clin Med Phys; 2012 Nov; 13(6):3769. PubMed ID: 23149772
[TBL] [Abstract][Full Text] [Related]
8. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
10. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques.
Cella L; Liuzzi R; Magliulo M; Conson M; Camera L; Salvatore M; Pacelli R
Radiat Oncol; 2010 May; 5():33. PubMed ID: 20459790
[TBL] [Abstract][Full Text] [Related]
12. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
13. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
Aznar MC; Maraldo MV; Schut DA; Lundemann M; Brodin NP; Vogelius IR; Berthelsen AK; Specht L; Petersen PM
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):169-74. PubMed ID: 25754634
[TBL] [Abstract][Full Text] [Related]
14. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.
Koeck J; Abo-Madyan Y; Eich HT; Stieler F; Fleckenstein J; Kriz J; Mueller RP; Wenz F; Lohr F
Strahlenther Onkol; 2012 Aug; 188(8):653-9. PubMed ID: 22740169
[TBL] [Abstract][Full Text] [Related]
17. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
18. Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease.
Lautenschlaeger S; Iancu G; Flatten V; Baumann K; Thiemer M; Dumke C; Zink K; Hauswald H; Vordermark D; Mauz-Körholz C; Engenhart-Cabillic R; Eberle F
Radiat Oncol; 2019 Sep; 14(1):157. PubMed ID: 31477141
[TBL] [Abstract][Full Text] [Related]
19. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
20. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]